NKILA and BOLA3-AS1 have been identified as unfavorable factors for colon cancer (Xu et al., 2021a; Guo et al., 2021; Chen et al., 2022; Qiu et al., 2022), which is consistent with the findings of this study. Here, NKILA is linked to colonic neoplasm.